Adverum Biotechnologies Inc

Overview

Adverum Biotechnologies Inc (Adverum) formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes ADVM-022 for Wet AMD and ADVM-022 for DME. Its products are used for treatment of unmet medical needs in ocular and rare diseases. Adverum’s ADVM-022 is a single, in-office intravitreal (“IVT”) injection gene therapy which improves the real-world vision outcomes for patients. The company has collaborations with academic institutions and pharmaceutical companies. It also offers research and development, pre-clinical services, and manufacturing services. The company operates in the US, the UK, and France. Adverum is headquartered in Redwood City, California, the US.
Key Stats
Address
800 Saginaw Drive, REDWOOD CITY, California
Headquarters

United States of America

Contact

1 650 2726269

Website
adverum.com
No of Employees

167

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

ADVM [NASD]

Revenue (2019)

$0 m

-100% (2019 vs 2018)
Net Income (2020)

$-118 m

-83% (2020 vs 2019)
Net Profit Margin

-25794 %

-472.5% (2019 vs 2018)
Market Cap *

$226 m

EPS *

$-1.4

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Adverum Biotechnologies IncPTC Therapeutics IncVoyager Therapeutics IncTRACON Pharmaceuticals Inc
Key Information
Headquarters United States of America United States of America United States of America United States of America
Headquarter City REDWOOD CITY SOUTH PLAINFIELD CAMBRIDGE SAN DIEGO
Headquarter State/Province California New Jersey Massachusetts California
No. of Employees 167 967 177 18
Entity Type Public Public Public Public

Products & Services

Adverum is a pharmaceutical company. The key products and services of the company include the following:

Products
  • ADVM-022 for Wet AMD
  • ADVM-022 for DME
Services
  • Reserch and Development
  • Pre Clinical
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2017 Acquisitions/Mergers/Takeovers In August,Adverum Biotechnologies acquired Annapurna Therapeutics SAS.
2016 Plans/Strategy In April, Avalanche Biotechnologies, Inc. and its research partner Regeneron planned to present new technologies…
2016 Contracts/Agreements In August, Adverum Biotechnologies entered into a collaboration with Editas Medicine, Inc. for exploring the…
2016 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2015 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2015 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Annapurna Therapeutics SAS

Address

183 Avenue De Choisy, Paris
France

Telephone

33 6 79 53 24 46

Website

www.annapurnatx.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
01 Mar 2021 LEXEO Therapeutics Enters into Licensing Agreement with Adverum Biotech Licensing Agreement LEXEO Therapeutics LLC Adverum Biotechnologies Inc
11 Aug 2020 Adverum Biotech Raises USD216.8 Million in Public Offering of Shares Equity Offering Adverum Biotechnologies Inc
10 Feb 2020 Adverum Biotech Raises USD150.2 Million in Public Offering of Shares Equity Offering Adverum Biotechnologies Inc
07 Feb 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
23 Aug 2017 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
09 Aug 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

10

Active Jobs

8

Posted

6

Closed

Job Trends

Latest Jobs

Job title Company Country
Downstream Pilot Process Development Associate (Contract) Adverum Biotechnologies Inc United States
Lab Manager, Pilot Process Development (Contract) Adverum Biotechnologies Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar